Clinical Trials in Baltimore

Showing 6641-6660 of 17,842 trials

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

NCT04575896

In this study, individuals without hepatitis C infection who are on the kidney transplant waitlist will receive a kidney from a deceased donor with hepatitis C infection and will be treated for hepatitis C at the same time. Treatment will include glecaprevir 300 mg / pibrentasvir 120 mg (G-P) administered on-call to the operating room for the renal transplant procedure and continued for 2 weeks post-renal transplant.

End Stage Renal DiseaseHepatitis C

Johns Hopkins University10 participantsStarted Nov 2020

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

NCT03585270

This study will evaluate if clazosentan (on top of normal routine medical care) can reduce the risk of developing complications related to cerebral vasospasm and permanent brain damage as compared to normal routine medical care alone.

Aneurysmal Subarachnoid Hemorrhage

Idorsia Pharmaceuticals Ltd.409 participantsStarted Feb 2019

Stanford, California, United States • Jacksonville, Florida, United States • Chicago, Illinois, United States +77 more locations

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

Find Trials by Condition in Baltimore

Virtual Sailing Simulator in Individuals With Spinal Cord Injury

Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults

Sirolimus to Treat Diabetic Macular Edema

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

A Post-Approval Study of the LINX® Reflux Management System

A Study of OV101 in Individuals With Angelman Syndrome (AS)

A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis

A Study of PTC923 in Participants With Phenylketonuria

Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

Coflex PS3 Actual Conditions for Use Study

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine

Study Evaluating Betrixaban in Pediatric Participants

Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)

Non-Myeloablative Conditioning and Bone Marrow Transplantation

Diffusion-Weighted MRI for Liver Metastasis

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19